Over and above its pain-relieving results, conolidine has demonstrated a good basic safety margin in preclinical toxicology assessments. In contrast to opioids, which frequently result in respiratory despair at bigger doses, conolidine has not developed indications of significant respiratory suppression. Also, behavioral assessments in murine designs suggest an absence https://carlf356ibr4.wikipowell.com/user